0001209191-23-016455.txt : 20230306
0001209191-23-016455.hdr.sgml : 20230306
20230306181339
ACCESSION NUMBER: 0001209191-23-016455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Mark
CENTRAL INDEX KEY: 0001658379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 23710318
MAIL ADDRESS:
STREET 1: 25 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-02
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001658379
Coleman Mark
C/O AXSOME THERAPEUTICS, INC.
22 CORTLANDT STREET, 16TH FLOOR
NEW YORK
NY
10007
1
0
0
0
Stock Option (Right to Buy)
65.32
2023-03-02
4
A
0
2870
0.00
A
2023-03-02
2033-03-01
Common Stock
2870
2870
D
Represents 2,870 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable.
/s/ Herriot Tabuteau, M.D., Attorney in Fact
2023-03-06